Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine

Background One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-piperaquine (DHA-PQ). However, the pharmacokinetics of piperaquine and the relationship between drug levels and clinical efficacy are incompletely characterized, particularly in children. Methods We per...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Zongo, I, Somé, F, Somda, SA, Parikh, S, Rouamba, N, Rosenthal, P, Tarning, J, Lindegardh, N, Nosten, F, Ouédraogo, J
Format:	Journal article
Język:	English
Wydane:	Public Library of Science 2014

Podobne zapisy

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
od: Issaka Zongo, i wsp.
Wydane: (2014-01-01)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
od: Tarning, J, i wsp.
Wydane: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
od: Tarning, J, i wsp.
Wydane: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
od: Tarning, J, i wsp.
Wydane: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
od: Tarning, J, i wsp.
Wydane: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
od: Rijken, M, i wsp.
Wydane: (2011)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
od: Tarning, J, i wsp.
Wydane: (2007)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
od: Creek, D, i wsp.
Wydane: (2013)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
od: Chotsiri, P, i wsp.
Wydane: (2019)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
od: Palang Chotsiri, i wsp.
Wydane: (2019-01-01)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
od: Tarning, J, i wsp.
Wydane: (2008)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
od: Mytton, O, i wsp.
Wydane: (2007)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
od: Adam, I, i wsp.
Wydane: (2012)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
od: Zongo, I, i wsp.
Wydane: (2015)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
od: Adam, I, i wsp.
Wydane: (2012)

Efficacy and safety of dihydroartemisinin-piperaquine.
od: Myint, H, i wsp.
Wydane: (2007)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
od: Tarning, J, i wsp.
Wydane: (2014)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
od: Benjamin Abuaku, i wsp.
Wydane: (2023-01-01)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenafi Assefa, i wsp.
Wydane: (2022-12-01)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
od: Permala, J, i wsp.
Wydane: (2017)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
od: Ashley, E, i wsp.
Wydane: (2010)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenaf Assefa, i wsp.
Wydane: (2023-04-01)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
od: Ashley, E, i wsp.
Wydane: (2010)

Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
od: Abraham Rexford Oduro, i wsp.
Wydane: (2019-01-01)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
od: Byakika-Kibwika, P, i wsp.
Wydane: (2019)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
od: Phuc, B, i wsp.
Wydane: (2017)

Quantification of the antimalarial piperaquine in plasma.
od: Tarning, J, i wsp.
Wydane: (2008)

Brugada syndrome precipitated by uncomplicated malaria treated with dihydroartemisinin piperaquine: a case report
od: Muzakkir Amir, i wsp.
Wydane: (2024-09-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
od: Hadjar Siswantoro, i wsp.
Wydane: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
od: Hadjar Siswantoro, i wsp.
Wydane: (2015-01-01)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
od: Rijken, M, i wsp.
Wydane: (2007)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
od: Ashley, E, i wsp.
Wydane: (2004)

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial
od: Kamya, MR, i wsp.
Wydane: (2007)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
od: Hoglund, R, i wsp.
Wydane: (2012)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
od: Bui Quang Phuc, i wsp.
Wydane: (2017-04-01)

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
od: Karema, C, i wsp.
Wydane: (2006)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
od: Wanting Wu, i wsp.
Wydane: (2021-02-01)

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
od: Price, R, i wsp.
Wydane: (2007)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
od: Lwin, K, i wsp.
Wydane: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
od: Lwin, K, i wsp.
Wydane: (2012)